Cargando…
One Century of Study: What We Learned about Paracoccidioides and How This Pathogen Contributed to Advances in Antifungal Therapy
Paracoccidioidomycosis (PCM) is a notable fungal infection restricted to Latin America. Since the first description of the disease by Lutz up to the present day, Brazilian researchers have contributed to the understanding of the life cycle of this pathogen and provided the possibility of new targets...
Autores principales: | Seki Kioshima, Erika, de Souza Bonfim de Mendonça, Patrícia, de Melo Teixeira, Marcus, Grenier Capoci, Isis Regina, Amaral, André, Vilugron Rodrigues-Vendramini, Franciele Abigail, Lauton Simões, Bruna, Rodrigues Abadio, Ana Karina, Fernandes Matos, Larissa, Soares Felipe, Maria Sueli |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7913102/ https://www.ncbi.nlm.nih.gov/pubmed/33540749 http://dx.doi.org/10.3390/jof7020106 |
Ejemplares similares
-
Promising antifungal activity of new oxadiazole against Candida krusei
por: Faria, Daniella Renata, et al.
Publicado: (2020) -
Two New 1,3,4-Oxadiazoles With Effective Antifungal Activity Against Candida albicans
por: Capoci, Isis Regina Grenier, et al.
Publicado: (2019) -
Antifungal activity of two oxadiazole compounds for the paracoccidioidomycosis treatment
por: Rodrigues-Vendramini, Franciele Abigail Vilugron, et al.
Publicado: (2019) -
Identification of New Antifungal Compounds Targeting Thioredoxin Reductase of Paracoccidioides Genus
por: Abadio, Ana Karina Rodrigues, et al.
Publicado: (2015) -
Fungicidal Activity of a Safe 1,3,4-Oxadiazole Derivative Against Candida albicans
por: Faria, Daniella Renata, et al.
Publicado: (2021)